Micro-Hydroxyapatite: What It Is, How It Works, and What the Research Actually Found
|
|
Time to read 11 min
|
|
Time to read 11 min
A science-grounded guide to the active ingredient at the heart of Peg Paste — and the clinical research behind it.
Your teeth are made of minerals. Around 97 percent of tooth enamel is a calcium phosphate mineral called hydroxyapatite. It is the primary building block of your teeth.
That is what makes it so interesting as an oral care ingredient. When hydroxyapatite is used in toothpaste, it works with your tooth structure. It deposits the same mineral building blocks back onto surfaces that daily acid exposure, food, and brushing gradually strip away.
At Peg Paste, we use micro-hydroxyapatite. Not nano. Micro. And there is a specific reason for that choice, one grounded in the clinical evidence rather than the marketing landscape.
This is what we found when we followed the research.
Hydroxyapatite is the mineral your teeth are built from. Enamel is approximately 97 percent hydroxyapatite by weight. The layer underneath, dentine, is around 70 percent.
When hydroxyapatite particles are applied to teeth during brushing, they interact with the enamel surface. Calcium and phosphate ions are released and taken up by areas where mineral has been lost, supporting the natural remineralisation process that occurs throughout the day.
The word biomimetic gets used a lot in this space. Here it means something precise: hydroxyapatite is structurally identical to the mineral your teeth are made from. It does not approximate it. It is it.
Microcrystalline refers to the particle size and crystal form. The particles are measured in micrometres rather than nanometres. They are larger, and structurally closer to the crystal form found in natural human enamel. That distinction matters in a real-world brushing context, and we will come back to it.
When you brush, hydroxyapatite particles are carried to the tooth surface. Several things happen from there, all documented in the published literature.
The particles adhere directly to the enamel surface, filling microscopic surface defects and demineralised pores. Because they share the same mineral composition as the tooth, there is a natural chemical affinity at work.
A 2020 laboratory study grew Streptococcus mutans biofilms, the bacteria most associated with dental caries, and added hydroxyapatite to the system. When the bacteria produced acid, the hydroxyapatite released calcium ions into the biofilm. The pH in the hydroxyapatite group was around 0.5 units higher than the control groups. When acid attacks, hydroxyapatite releases calcium and acts as a buffer, reducing the acid's ability to demineralise the tooth surface at exactly the moment it matters most.
There is also a sensitivity mechanism. Exposed dentinal tubules are the microscopic channels in dentine that, when open, transmit sensations from hot, cold, and pressure to the nerve. Hydroxyapatite particles physically block those channels. A 2023 meta-analysis covering 44 clinical trials found that hydroxyapatite reduced dentin hypersensitivity by 39.5 percent compared to placebo, and outperformed fluoride by 23 percent in head-to-head comparisons.
Multiple in-situ studies have also shown that hydroxyapatite reduces initial bacterial colonisation on enamel surfaces, competing with bacteria for the tooth surface and reducing the attachment that allows plaque to form.
A: exposed dentine at gum recession. B: open dentinal tubules with nerve endings. C: SEM image of two open tubules. D: brushing HAP toothpaste onto surface. E: HAP layer after one application. F: tubules fully occluded after regular use, sensitivity resolved.
Attribution: Limeback H, Enax J, Meyer F. Biomimetics 2023, 8(1), 23. doi:10.3390/biomimetics8010023
Laboratory evidence tells you about mechanism. Clinical evidence, randomised controlled trials with real people over real time periods, tells you what actually happens in practice. That distinction is important, and it is where the hydroxyapatite research becomes particularly compelling.
Here are the key studies.
Schlagenhauf et al. (2019) — Orthodontic patients, 6 months
This randomised controlled trial enrolled orthodontic patients, one of the highest-risk groups for enamel damage. Braces create additional surfaces where plaque accumulates and acid attacks are concentrated.
Participants used either a microcrystalline hydroxyapatite toothpaste or a fluoride toothpaste containing 1,400 ppm fluoride for six months. Caries progression was assessed using the International Caries Detection and Assessment System, the gold standard for tracking even early, non-cavitated lesions. The microcrystalline hydroxyapatite toothpaste was not inferior to the high-fluoride control. In an extremely caries-susceptible population, using no fluoride, micro-HA performed comparably to one of the stronger fluoride formulations available.
Schlagenhauf et al. (2019). Journal of Investigative and Clinical Dentistry.
Paszynska et al. (2021) — Children aged 3 to 7, 1 year
Published in Scientific Reports, this double-blinded randomised controlled trial enrolled 207 children at high risk for early childhood caries. Children brushed three times daily with either a microcrystalline hydroxyapatite toothpaste or a fluoride control for 336 days.
This was the first clinical trial of its kind in children. Caries progression was observed in 72.7 percent of the hydroxyapatite group and 74.2 percent of the fluoride group. Statistically equivalent. The microcrystalline hydroxyapatite toothpaste was non-inferior to fluoride.
The authors also noted something with practical significance for families. Unlike fluoride, hydroxyapatite poses no risk when swallowed, which matters for young children who routinely ingest a portion of their toothpaste.
Paszynska et al. (2021). Scientific Reports, 11, 2650.
Paszynska et al. (2023) — Adults aged 18 to 45, 18 months
This is the longest of the three trials. An 18-month double-blinded randomised controlled trial in 189 adults, testing 10 percent hydroxyapatite against 1,450 ppm sodium fluoride, one of the most common fluoride concentrations in mainstream toothpaste worldwide.
No increase in the DMFS caries index was observed in 89.3 percent of the hydroxyapatite group versus 87.4 percent of the fluoride group. The two products performed equivalently.
The mean DMFS increase over 18 months was 0.02 in the hydroxyapatite group and 0.31 in the fluoride group. The study was not powered to detect superiority, so the difference was not statistically significant. But the numerical trend favoured hydroxyapatite. The authors noted this was the third consecutive clinical trial confirming non-inferiority, with a consistent tendency for hydroxyapatite to trend better than its fluoride comparator.
Across three consecutive randomised controlled trials, in orthodontic patients, in children, and in adults, microcrystalline hydroxyapatite toothpaste was non-inferior to fluoride in preventing dental caries. In the adult trial, the numerical result favoured hydroxyapatite.
Paszynska et al. (2023). Frontiers in Public Health, 11, 1199728.
Limeback, Enax and Meyer (2023) — 44-trial sensitivity meta-analysis
A 2023 systematic review and meta-analysis assessed 44 published clinical trials on hydroxyapatite and dentin hypersensitivity. The result: hydroxyapatite reduced sensitivity by 39.5 percent compared to placebo, and by 23 percent compared to fluoride. The authors concluded hydroxyapatite is a more effective agent than fluoride for managing dentin hypersensitivity.
Limeback, Enax, Meyer (2023). Biomimetics, 8(1), 23.
Meyer, Limeback and Enax (2023) — 62-trial clinical evidence review
A comprehensive 2023 review surveyed the total clinical trial evidence base for hydroxyapatite in toothpaste, covering 62 published trials across caries prevention, dentin hypersensitivity, periodontal health, erosion protection, and whitening.
Conclusion: based on the current clinical evidence, fluoride-free hydroxyapatite is the most versatile and well-evidenced calcium phosphate ingredient in toothpaste.
Meyer, Limeback, Enax (2023). Biomimetics, 8(4), 331.
When we were building the Peg Paste formula, nano-hydroxyapatite was already the dominant form being marketed. Most of the oral care brands coming to market with hydroxyapatite were using it. It was positioned as the most advanced option.
We looked at it carefully. And the more we looked, the more questions we had.
Nano-hydroxyapatite does not exist in nature. It is engineered in a laboratory to shrink the mineral down to an ultra-small particle size, typically below 100 nanometres. Those ultra-small particles behave differently to larger ones. They carry more surface area per unit of volume, which is why they attracted research interest in the first place. But that same property, extreme smallness, is also what raises questions.
Nanoparticles do not always stay where you put them. They can interact with cells and tissues in ways that larger particles cannot. Some research has raised theoretical concerns about whether nanoparticles can cross biological barriers, be absorbed into tissues, or behave in unexpected ways over long-term daily exposure. The science is still active in this area. That alone gave us pause.
There is also a shape question that does not get discussed enough. Not all hydroxyapatite nanoparticles are the same shape. Rod-shaped particles within certain size ranges have been evaluated for safety. Needle-like particles have not been cleared, because early research suggested they may be more biologically reactive. Most products do not disclose the shape or surface treatment of the nanoparticles they use. You are largely taking it on trust.
We also had a simpler concern. People use toothpaste twice a day, every day. The mouth is one of the most absorbent surfaces in the body. In other areas of health and wellness, people scrutinise synthetic, lab-engineered ingredients carefully. Toothpaste often gets a pass. We did not think it should.
Microcrystalline hydroxyapatite particles are measured in micrometres, around 1,000 times larger than nanoparticles. They are not engineered to penetrate. They work at the surface of the enamel, physically adhering, depositing mineral, and buffering acid. That surface action is exactly what the three clinical trials above measured, and the results were non-inferior to fluoride across orthodontic patients, children, and adults over 18 months.
We chose micro because the clinical evidence was stronger in human trials, the ingredient stays closer to the form found in nature, and we were comfortable recommending it to people who use it every single day of their lives.
Micro-hydroxyapatite works at the surface of your enamel. It is the same mineral your teeth are made from, in a form that does not require engineering to an ultra-small particle size to do its job.
When Dr Cate Gerber (BDSc, Smile Studio Newstead) joined Peg Paste as Chief Dental Officer, we already had the formulation. The micro-HA decision had already been made.
One of the first things she did was review our formulation against the clinical evidence base. Her conclusion aligned with what had led us there in the first place. She was not retrofitting a justification. She was reading the same body of research and arriving at the same place independently.
"Hydroxyapatite has a long history in oral care research, particularly in Japan where it has been studied and used in toothpaste formulations for decades. What excites me about Peg Paste is that it brings a well-formulated micro-hydroxyapatite product to Australian bathrooms, made to a standard I am happy putting my name to." — Dr Cate Gerber, Chief Dental Officer.
That independent alignment matters to us. We are not asking you to take our word for it. We are telling you what the research showed and letting you decide.
Every time you eat or drink, the acids produced by oral bacteria begin dissolving minute quantities of mineral from your enamel. Every time you brush with a hydroxyapatite toothpaste, you are reintroducing that mineral, in a form chemically identical to what was lost, directly to the tooth surface.
The studies above suggest that when this is done consistently with a well-formulated microcrystalline hydroxyapatite toothpaste, the clinical outcome is comparable to fluoride across multiple age groups, over clinically meaningful time periods, in high-risk populations.
That is the foundation behind Peg Paste. We followed the evidence. This is where it led.
REFERENCES
References
Schlagenhauf et al. (2019). Impact of a non-fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries-susceptible orthodontic patients: a randomized, controlled 6-month trial. Journal of Investigative and Clinical Dentistry.
https://pubmed.ncbi.nlm.nih.gov/30701704/
2. Paszynska et al. (2021). Impact of a toothpaste with microcrystalline hydroxyapatite on the occurrence of early childhood caries: a 1-year randomized clinical trial. Scientific Reports, 11, 2650.
https://www.nature.com/articles/s41598-021-81112-y
3. Paszynska et al. (2023). Caries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial. Frontiers in Public Health, 11, 1199728.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393266/
4. Limeback, Enax, Meyer (2023). Clinical Evidence of Biomimetic Hydroxyapatite in Oral Care Products for Reducing Dentin Hypersensitivity: An Updated Systematic Review and Meta-Analysis. Biomimetics, 8(1), 23.
https://www.mdpi.com/2313-7673/8/1/23
5. Meyer, Limeback, Enax (2023). Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence. Biomimetics, 8(4), 331.
https://www.mdpi.com/2313-7673/8/4/331
6. Cieplik et al. (2020). Ca2+ release and buffering effects of synthetic hydroxyapatite following bacterial acid challenge. BMC Oral Health, 20, 85.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-020-01080-z
7. Limeback, Enax, Meyer (2021). Biomimetic hydroxyapatite and caries prevention: a systematic review and meta-analysis. Canadian Journal of Dental Hygiene, 55(3), 148-159.
https://pubmed.ncbi.nlm.nih.gov/34925515/
This article is an editorial summary of a publicly available peer-reviewed clinical trial. It does not constitute dental or medical advice, and makes no therapeutic claims about any specific product. The research summarised was conducted independently of Peg Paste. Individual results may vary. Always consult a qualified dental professional for personal oral health advice. Peg Paste Pty Ltd, Noosa Heads QLD Australia.
Hydroxyapatite is a restorative mineral that occurs naturally in teeth and bones. Hydroxyapatite works to repair, remineralise and strengthen the tooth’s outer layer, acting as a buffer to help prevent mineral loss, tooth erosion, tooth sensitivity and plaque.
Prebiotics support oral health by promoting the growth of beneficial bacteria, which can help maintain a balanced environment in the mouth. It is important to maintain good oral hygiene so harmful bacteria does not take over potentially leading to bad breath, cavities and disease.
Peg Paste is made and manufactured in Australia.
We use micro-hydroxyapatite in our toothpaste and ensure that it fully complies with current SCCS (Scientific Committee on Consumer Safety) and Australian oral care and cosmetic regulations. We are aware of the European Union’s upcoming ban on nano-materials in cosmetics starting November 2025. The reason for this ban is still unclear, but reports suggest potential risks if nano-hydroxyapatite is used in high concentrations or in sprayable products, where inhalation could be a concern. Since our toothpaste is not a spray and is formulated with concentrations that are within safe guidelines, we remain confident in its safety and effectiveness.
Absolutely. Prevention is key when it comes to oral health, so why not instil healthy habits early. Children’s toothpaste normally consists of a lower level or no fluoride because of the greater risk of potential fluoride toxicity. Given Peg Paste is a natural, fluoride-free formulation, it is safe for junior toothypegs. We recommend children use a pea size amount and brush under adult supervision.
Science shows that Hydroxyapatite helps ease tooth sensitivity by filling in microscopic pathways to the nerves in the teeth. With fewer pathways exposed, the less sensitivity and discomfort you should feel to touch, food and temperature. Remember to always consult your dental professional for oral health advice and before trying new products.
Peg Paste does not contain Sodium Lauryl Sulfate or SLS, a common ingredient that acts as a thickener in toothpaste products. SLS can have negative, degenerative effects that can contribute to, or worsen serious oral health issues such as dry mouth, mouth ulcers, mouth irritation and bad breath. Changing to an SLS free toothpaste can make a difference if you’re experiencing these symptoms. Remember to always consult your dentist or dental hygienist for oral health advice and before trying new products.
You are currently shipping to Australia and your order will be billed in AUD $.